Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helen Mossop

Showing results (11-20 of 29) with videos related to

Pageof 3
Sort By:
Trials|March 22, 2026
Towards high-quality and timely interim analyses in adaptive trials: a scoping review of best practice and evidence gapsKatie H Thomson, Opeyemi Agbeleye, Chizoba Oparah, et al.
Pilot and Feasibility Studies|September 27, 2025
Control, Fludrocortisone or Midodrine for the treatment of Orthostatic Hypotension (CONFORM-OH): results from an internal pilot randomised controlled trialHelen Mossop, Sarah Al-Ashmori, Tumi Sotire, et al.
Clinical and Translational Radiation Oncology|February 20, 2020
Evaluation of erectile potency and radiation dose to the penile bulb using image guided radiotherapy in the CHHiP trialJulia Murray, Sarah Gulliford, Clare Griffin, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 27, 2019
A randomised assessment of image guided radiotherapy within a phase 3 trial of conventional or hypofractionated high dose intensity modulated radiotherapy for prostate cancerJulia Murray, Clare Griffin, Sarah Gulliford, et al.
JAMA Network Open|April 21, 2026
Invasive vs Conservative Strategy for Frail Older Patients With Myocardial Infarction: A Secondary Analysis of the SENIOR-RITA Randomized Clinical TrialFrancesca Rubino, Helen Mossop, David P Ripley, et al.
BMJ (Clinical Research Ed.)|March 10, 2022
Alternative to prophylactic antibiotics for the treatment of recurrent urinary tract infections in women: multicentre, open label, randomised, non-inferiority trialChris Harding, Helen Mossop, Tara Homer, et al.
Health Technology Assessment (Winchester, England)|November 16, 2021
Ondansetron and metoclopramide as second-line antiemetics in women with nausea and vomiting in pregnancy: the EMPOWER pilot factorial RCTStephen Robson, Catherine McParlin, Helen Mossop, et al.
Health Technology Assessment (Winchester, England)|May 10, 2022
Methenamine hippurate compared with antibiotic prophylaxis to prevent recurrent urinary tract infections in women: the ALTAR non-inferiority RCTChris Harding, Thomas Chadwick, Tara Homer, et al.
Radiology|November 23, 2016
Diffusion-weighted Imaging as a Treatment Response Biomarker for Evaluating Bone Metastases in Prostate Cancer: A Pilot StudyRaquel Perez-Lopez, Joaquin Mateo, Helen Mossop, et al.
The Lancet. Oncology|November 3, 2015
Hypofractionated radiotherapy versus conventionally fractionated radiotherapy for patients with intermediate-risk localised prostate cancer: 2-year patient-reported outcomes of the randomised, non-inferiority, phase 3 CHHiP trialAnna Wilkins, Helen Mossop, Isabel Syndikus, et al.
Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Trials|March 22, 2026
Towards high-quality and timely interim analyses in adaptive trials: a scoping review of best practice and evidence gapsKatie H Thomson, Opeyemi Agbeleye, Chizoba Oparah, et al.
Pilot and Feasibility Studies|September 27, 2025
Control, Fludrocortisone or Midodrine for the treatment of Orthostatic Hypotension (CONFORM-OH): results from an internal pilot randomised controlled trialHelen Mossop, Sarah Al-Ashmori, Tumi Sotire, et al.
Clinical and Translational Radiation Oncology|February 20, 2020
Evaluation of erectile potency and radiation dose to the penile bulb using image guided radiotherapy in the CHHiP trialJulia Murray, Sarah Gulliford, Clare Griffin, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 27, 2019
A randomised assessment of image guided radiotherapy within a phase 3 trial of conventional or hypofractionated high dose intensity modulated radiotherapy for prostate cancerJulia Murray, Clare Griffin, Sarah Gulliford, et al.
JAMA Network Open|April 21, 2026
Invasive vs Conservative Strategy for Frail Older Patients With Myocardial Infarction: A Secondary Analysis of the SENIOR-RITA Randomized Clinical TrialFrancesca Rubino, Helen Mossop, David P Ripley, et al.
BMJ (Clinical Research Ed.)|March 10, 2022
Alternative to prophylactic antibiotics for the treatment of recurrent urinary tract infections in women: multicentre, open label, randomised, non-inferiority trialChris Harding, Helen Mossop, Tara Homer, et al.
Health Technology Assessment (Winchester, England)|November 16, 2021
Ondansetron and metoclopramide as second-line antiemetics in women with nausea and vomiting in pregnancy: the EMPOWER pilot factorial RCTStephen Robson, Catherine McParlin, Helen Mossop, et al.
Health Technology Assessment (Winchester, England)|May 10, 2022
Methenamine hippurate compared with antibiotic prophylaxis to prevent recurrent urinary tract infections in women: the ALTAR non-inferiority RCTChris Harding, Thomas Chadwick, Tara Homer, et al.
Radiology|November 23, 2016
Diffusion-weighted Imaging as a Treatment Response Biomarker for Evaluating Bone Metastases in Prostate Cancer: A Pilot StudyRaquel Perez-Lopez, Joaquin Mateo, Helen Mossop, et al.
The Lancet. Oncology|November 3, 2015
Hypofractionated radiotherapy versus conventionally fractionated radiotherapy for patients with intermediate-risk localised prostate cancer: 2-year patient-reported outcomes of the randomised, non-inferiority, phase 3 CHHiP trialAnna Wilkins, Helen Mossop, Isabel Syndikus, et al.
Pageof 3